BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19119252)

  • 1. Hepatocyte nuclear factor 1-alpha mutation in normal glucose-tolerant subjects and early-onset type 2 diabetic patients.
    Lim DM; Huh N; Park KY
    Korean J Intern Med; 2008 Dec; 23(4):165-9. PubMed ID: 19119252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
    Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
    Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
    Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
    Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
    Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
    Hwang JS; Shin CH; Yang SW; Jung SY; Huh N
    Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the hepatocyte nuclear factor-1 alpha gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese.
    Nishigori H; Yamada S; Kohama T; Utsugi T; Shimizu H; Takeuchi T; Takeda J
    J Hum Genet; 1998; 43(2):107-10. PubMed ID: 9621514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes.
    Doria A; Yang Y; Malecki M; Scotti S; Dreyfus J; O'Keeffe C; Orban T; Warram JH; Krolewski AS
    Diabetes Care; 1999 Feb; 22(2):253-61. PubMed ID: 10333942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus.
    Yorifuji T; Fujimaru R; Hosokawa Y; Tamagawa N; Shiozaki M; Aizu K; Jinno K; Maruo Y; Nagasaka H; Tajima T; Kobayashi K; Urakami T
    Pediatr Diabetes; 2012 Feb; 13(1):26-32. PubMed ID: 22060211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians.
    Anuradha S; Radha V; Deepa R; Hansen T; Carstensen B; Pedersen O; Mohan V
    Diabetes Care; 2005 Oct; 28(10):2430-5. PubMed ID: 16186275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
    Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; Urhammer SA; Holst JJ; Almind K; Echwald SM; Hansen L; Bell GI; Pedersen O
    Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes.
    Møller AM; Dalgaard LT; Pociot F; Nerup J; Hansen T; Pedersen O
    Diabetologia; 1998 Dec; 41(12):1528-31. PubMed ID: 9867222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea.
    Lee HJ; Ahn CW; Kim SJ; Song YD; Lim SK; Kim KR; Lee HC; Huh KB
    Acta Diabetol; 2001; 38(3):123-7. PubMed ID: 11827432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte nuclear factor-α genetic mutation in a Chinese pedigree with maturity-onset diabetes of the young (MODY3).
    Zhang M; Wang T; Shi L; Yang Y
    Diabetes Metab Res Rev; 2015 Oct; 31(7):767-70. PubMed ID: 26436572
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
    Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.
    Bellanné-Chantelot C; Lévy DJ; Carette C; Saint-Martin C; Riveline JP; Larger E; Valéro R; Gautier JF; Reznik Y; Sola A; Hartemann A; Laboureau-Soares S; Laloi-Michelin M; Lecomte P; Chaillous L; Dubois-Laforgue D; Timsit J;
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1346-51. PubMed ID: 21677039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).
    McKinney JL; Cao H; Robinson JF; Metzger DL; Cummings E; Riddell DC; Sanderson SR; Pacaud D; Ho J; Hegele RA
    Clin Invest Med; 2004 Jun; 27(3):135-41. PubMed ID: 15305805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
    Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
    Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.